Department of Spine Surgery, Lilavati Hospital and Research Centre, Mumbai, Maharashtra, India.
Global Hospital, Mumbai, Maharashtra, India.
Eur Spine J. 2024 Apr;33(4):1369-1380. doi: 10.1007/s00586-024-08155-3. Epub 2024 Mar 3.
Sarcopenia, defined as progressive impairment of muscle function secondary to loss of skeletal muscle mass, has prevalence of 24-56% in patients > 60 years. Forty-four per cent of elderly patients undergoing orthopaedic surgery are found to be sarcopenic. It is a known risk factor for fall, fractures, disability, increased post-operative morbidity and mortality. If diagnosed pre-operatively, it can help prepare the patient and surgical team to foresee complications and thereby reduce morbidity and mortality. In the present study, we evaluated and correlated sarcopenia with the surgical outcome of operated patients with lumbar spine pathology.
A prospective, observational study was conducted on 114 patients > 40 years undergoing lumbar spine surgeries, who were studied and followed up for 3 months. They were segregated into 5 groups based on age (40-50 year, 50-60 year, 60-70 year, 70-80 year, and > 80 year) and were assessed separately. Data on demography, grip strength analysis, 30-s chair stand test, Psoas muscle index (calculated on pre-operative MRI), pre- and post-operative ODI (Oswestry Disability Index) scores at 2 weeks and 3 months, Dindo-Clavien Classification of peri-operative complications, 90-day readmission rates and mortality (if any) were included. Patients were segregated into sarcopenic and non-sarcopenic groups based on the definition and set parameters as per the European Working Group on Sarcopenia in Older People (EWGSOP). A comparative analysis between these groups was performed.
Of 114 patients, there were 18 patients in 40-49 years, 24 in 50-59 years, 33 in 60-69 years, 30 in 70-79 years and 9 in > 80 years age group. Statistically significant difference in peri-operative ODI scores was seen in sarcopenic vs non-sarcopenic patients in all age groups (p < 0.05) except 40-49 years. The results showed that sarcopenic group had higher rate of peri-operative complications, delayed mobilisation, longer stay and mortality compared to non-sarcopenic group.
We conclude that sarcopenic patients have poor outcome in lumbar spine surgery compared to those without. So, by diagnosing sarcopenia using tests routinely done as pre-operative requirement, one can reduce radiation exposure and cost of treatment. The management can be revolutionised by predicting those who are at high risk of developing post-operative complications and poor surgical outcomes by mere diagnosis of sarcopenia. This knowledge will benefit both the patients and the surgeons.
肌少症是一种由于骨骼肌质量减少而导致肌肉功能进行性下降的疾病,其在 60 岁以上患者中的患病率为 24%-56%。44%接受骨科手术的老年患者被发现患有肌少症。它是跌倒、骨折、残疾、术后发病率和死亡率增加的已知危险因素。如果在术前诊断出肌少症,它可以帮助患者和手术团队预测并发症,从而降低发病率和死亡率。在本研究中,我们评估并分析了肌少症与腰椎病变患者手术结果的相关性。
对 114 名年龄大于 40 岁的腰椎手术患者进行前瞻性、观察性研究,对这些患者进行研究并随访 3 个月。他们根据年龄(40-50 岁、50-60 岁、60-70 岁、70-80 岁和大于 80 岁)分为 5 组,分别进行评估。收集患者的人口统计学资料、握力分析、30 秒坐站测试、术前 MRI 测量的竖脊肌指数、术后 2 周和 3 个月的 Oswestry 功能障碍指数(ODI)评分、围手术期并发症的 Dindo-Clavien 分类、90 天内再入院率和死亡率(如有)。根据欧洲老年人肌少症工作组(EWGSOP)的定义和设定参数,将患者分为肌少症组和非肌少症组。对这些组进行了比较分析。
在 114 名患者中,40-49 岁 18 例,50-59 岁 24 例,60-69 岁 33 例,70-79 岁 30 例,大于 80 岁 9 例。在所有年龄组中,肌少症患者的围手术期 ODI 评分均明显高于非肌少症患者(p<0.05),但 40-49 岁组除外。结果显示,与非肌少症组相比,肌少症组的围手术期并发症、延迟活动、住院时间和死亡率更高。
我们的结论是,与无肌少症的患者相比,肌少症患者的腰椎手术结果较差。因此,通过在术前常规检查中诊断肌少症,可以减少辐射暴露和治疗费用。通过单纯诊断肌少症,就可以预测那些发生术后并发症和手术结局不良风险较高的患者,从而改变治疗管理方式。这一知识将使患者和外科医生受益。